Key result
Intranasal immunization of guinea pigs with a foot-and-mouth disease virus peptide conjugate without adjuvant provided full protection against homotypic virus challenge in 86% of animals.
Why the study?
Does intranasal immunization with a foot-and-mouth disease virus peptide conjugate induce antibodies and protection against challenge in guinea pigs?
Does intranasal immunization with a foot-and-mouth disease virus peptide conjugate induce antibodies and protection against challenge in guinea pigs?
Intranasal inoculation with a foot-and-mouth disease virus peptide conjugate without adjuvant offers a potential route of vaccination to elicit protection in the upper respiratory tracts of susceptible animals.
Answers are grounded in this paper and cite their sources.
Adjuvant-free intranasal peptide vaccination shows promise in guinea pigs; leaves open translation to livestock or other species.
Guinea pigs immunized intranasally with a keyhole limpet hemocyanin-linked peptide, corresponding to the prominent G-H loop of the VP1 protein of foot-and-mouth disease virus, raised substantial levels of antipeptide and virus-neutralizing antibodies in sera and of peptide-specific secretory immunoglobulin A in nasal secretions. In groups of animals immunized intranasally without adjuvant, 86 percent were fully protected upon challenge with homotypic virus. Surprisingly, animals given the peptide conjugates plus the mucosal adjuvant cholera toxin were afforded only partial protection in that primary lesions were observed in most animals, although spread to other feet was prevented. These results indicate that intranasal inoculation with the peptide offers a potential route of vaccination against foot-and-mouth disease and may be useful for eliciting protection in the upper respiratory tracts of susceptible animals.
No takes yet. Share an insight, caveat, or question.
Fischer et al. (2003) studied Foot-and-mouth disease. Intranasal immunization with a keyhole limpet hemocyanin-linked peptide vs. Peptide conjugates plus mucosal adjuvant cholera toxin was evaluated on Protection upon challenge with homotypic virus. Intranasal immunization of guinea pigs with a foot-and-mouth disease virus peptide conjugate without adjuvant provided full protection against homotypic virus challenge in 86% of animals.
Synapse has enriched 10 related papers. Consider them for comparative context: